Method Name
A short description of the method used to perform the test
Multi-Analyte Immunodetection (MAID)
NY State Available
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Reporting Name
Lists a shorter or abbreviated version of the Published Name for a test
N. meningitidis IgG Vacc Response
Aliases
Lists additional common names for a test, as an aid in searching
Meningococcal IgG Vaccine Response
N. Meningitidis IgG Vaccine Response
Specimen Type
Describes the specimen type validated for testing
Serum
Specimen Required
Defines the optimal specimen required to perform the test and the preferred volume to complete testing
Container/Tube:
Preferred: Red top tube
Acceptable: Serum gel tube
Specimen Volume: 0.5 mL
Collection Instructions: Draw blood in a plain red-top tube(s), serum gel tube(s) is acceptable. Spin down and send 0.5 mL of serum refrigerated in a plastic vial.
Note: Serum gel tube is acceptable, but must pour off into a plastic vial.
Specimen Minimum Volume
Defines the amount of sample necessary to provide a clinically relevant result as determined by the testing laboratory. The minimum volume is sufficient for one attempt at testing.
Reject Due To
Identifies specimen types and conditions that may cause the specimen to be rejected
Specimen Type |
Temperature |
Time |
Special Container |
Serum |
Refrigerated (preferred) |
14 days |
|
|
Frozen |
30 days |
|
|
Ambient |
7 days |
|
Reference Values
Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
Reference Ranges (pre-vaccination):
Serogroup A <4.0 ug/mL
Serogroup C <5.0 ug/mL
Serogroup Y <4.0 ug/mL
Serogroup W-135 <3.0 ug/mL
This assay measures serum IgG antibodies recognizing polysaccharide antigens from the four Neisseria meningitidis serogroups included in the licensed meningococcal vaccine. The meningococcal vaccine response is best evaluated by testing pre-vaccination and post-vaccination samples in parallel. A two-fold or greater increase for at least two sero-groups is expected when comparing post-vaccination to pre-vaccination results. N. meningitidis IgG levels peak approximately one month post-vaccination, but decline markedly by two years.
Fees :
Several factors determine the fee charged to perform a test. Contact your U.S. or International Regional Manager for information about establishing a fee schedule or to learn more about resources to optimize test selection.
- Authorized users can sign in to Test Prices for detailed fee information.
- Clients without access to Test Prices can contact Customer Service 24 hours a day, seven days a week.
- Prospective clients should contact their account representative. For assistance, contact Customer Service.
Test Classification
Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR) product.
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is use for clinical purposes.
Test Id |
Test Order Name |
Order LOINC Value
|
FNMEN |
N. meningitidis IgG Vacc Response |
Not Provided |
Result Id |
Test Result Name |
Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
|
Z0726 |
Serogroup A |
42986-0 |
Z0532 |
Serogroup C |
42985-2 |
Z0533 |
Serogroup Y |
39618-4 |
Z0534 |
Serogroup W-135 |
39610-1 |